Millions of Part D patients who rely on price-controlled drugs will see their out-of-pocket medication costs increase.

U.S. Senator Jacky Rosen announced that 15 additional medications have been selected for Medicare drug pricing negotiations, ...

The pharma expects a modest financial headwind this year from changes to Medicare prescription drug benefits under the ...

The Biden Administration and its congressional allies passed the ironically named Inflation Reduction Act (IRA) in 2022 ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...

As part of the Inflation Reduction Act, price negotiations with manufacturers will begin ... (CMS), announced that 15 new drugs that are currently covered under Medicare Part D will be selected for ...

Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...